News

Deal Announcements

Surface Logix Sees $20 Million Venture Capital

Wednesday, March 11, 2009 5:40:00 AM PDT | VentureDeal Staff
Brighton, Massachusetts  --  Biotechnology company Surface Logix has secured $20 million in a new round of venture debt and venture capital investment.

Surface Logix is developing small molecule drugs that it says will exhibit significantly improved pharmacokinetic and pharmacodynamic properties.

Investors in the round included Arch Venture Partners, HBM BioVentures, Healthcare Ventures, Intel Capital, Venrock, Unilever and MPM Capital. The company did not disclose how it would use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1